ProShare Advisors’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-122
| Closed | -$38K | – | 2095 |
|
|
2020
Q3 | $38K | Buy |
122
+6
| +5% | +$1.87K | ﹤0.01% | 1610 |
|
|
2020
Q2 | $43K | Buy |
+116
| New | +$43K | ﹤0.01% | 1630 |
|
|
2020
Q1 | – | Sell |
-140
| Closed | -$74K | – | 1335 |
|
|
2019
Q4 | $74K | Sell |
140
-15
| -10% | -$7.93K | ﹤0.01% | 1724 |
|
|
2019
Q3 | $67K | Sell |
155
-7
| -4% | -$3.03K | ﹤0.01% | 1578 |
|
|
2019
Q2 | $193K | Sell |
162
-22
| -12% | -$26.2K | ﹤0.01% | 1449 |
|
|
2019
Q1 | $229K | Buy |
184
+2
| +1% | +$2.49K | ﹤0.01% | 1390 |
|
|
2018
Q4 | $172K | Sell |
182
-35
| -16% | -$33.1K | ﹤0.01% | 1400 |
|
|
2018
Q3 | $313K | Sell |
217
-6
| -3% | -$8.65K | ﹤0.01% | 1330 |
|
|
2018
Q2 | $360K | Buy |
223
+64
| +40% | +$103K | ﹤0.01% | 1278 |
|
|
2018
Q1 | $258K | Sell |
159
-26
| -14% | -$42.2K | ﹤0.01% | 1406 |
|
|
2017
Q4 | $311K | Buy |
+185
| New | +$311K | ﹤0.01% | 1369 |
|